What they were paid
Cardiff Oncology Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $82,500 | $0 | $106,670 | $0 | $189,170 |
| FY2024 | $81,000 | — | $56,460 | — | $137,460 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cardiff Oncology, Inc. DEF 14A filed April 23, 2026, accession 0001213037-26-000006, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Cardiff Oncology pays directors a $65,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Cardiff Oncology board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Gary W. Pace | Independent Director | $184,170 |
| James O. Armitage | Independent Director | $175,670 |
| Mani Mohindru | Director | $183,670 |
| Renee P. Tannenbaum | Independent Director | — |
| Rodney S. Markin | Independent Director | $225,670 |
The full Cardiff Oncology compensation record
free company briefThis page is one director within Cardiff Oncology's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat